In a comparison of SLE development in Tlr7.1 transgenic mice with and without B cell‐specific Atg5 knockout, researchers observed that Tlr7.1 transgenic Atg5 knockout mice did not exhibit an IFN‐α signature in their serum.125. The gene discussed is ATG5; the disease is systemic lupus erythematosus.